InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by Dreyfus Andrew, Director. Director active across 1 company, notably Ironwood Pharmaceuticals INC. In total, 8 filings have been published. Activity tracked since 2 June 2021. The latest transaction was disclosed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Dreyfus Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
45,000 shares0Class A Common StockSEC:0000950170-25-085437:0
24,311 shares0Class A Common StockSEC:0000950170-24-076211:0
22,350 shares0Class A Common StockSEC:0001209191-23-039134:0
21,571 shares0Class A Common StockSEC:0001209191-22-033965:0
1,431 shares0Class A Common StockSEC:0001209191-21-070234:0
1,344 shares0Class A Common StockSEC:0001209191-21-056656:0
1,453 shares0Class A Common StockSEC:0001209191-21-040921:0
22,766 shares0Class A Common StockSEC:0001209191-21-038191:0
8 of 8 declarations
About Dreyfus Andrew
Andrew Dreyfus is a Board Member at Ironwood Pharmaceuticals Inc. He brings valuable expertise to the board, contributing to the company's strategy and governance. His experience in the pharmaceutical sector allows him to provide unique insights into market challenges and growth opportunities. His role is essential in guiding Ironwood towards a prosperous future.
